News

A vacancy is currently open for the key post of ELIXIR Technical Coordinator. The closing date for the post is 8 September 2013. The full job description is available here.

ELIXIR has produced a new brochure describing the first five ELIXIR Pilot Actions in more detail. The current Pilots included actions such as improving links between the Human Protein Atlas, hosted by the Swedish Node, and protein resources run by

Article in Nature News & Comment An article in Nature today outlines the challenges of handling large volumes of data in biology. It describes ELIXIR as "a project to help scientists across Europe safeguard and share their data, and to

ELIXIR has been featured as an example of a Research Infrastructure that has benefited from EU Structural Funds in a recent workshop summary report. The report is based on the discussions and presentations that took place at an event in

EMBL Council formally ratified the ELIXIR Consortium Agreement (ECA) during its meeting in Heidelberg on 26 June. The fifteen countries that have already signed the interim Memorandum of Understanding (MoU) will continue the process of ratifying the ECA in their

The pdf version of the new ELIXIR brochure is now available here.

On 30-31 May, technical experts from emerging ELIXIR Nodes came together to form ELIXIR’s first Technical Coordinator’s group. As a distributed e-infrastructure, many of the key challenges involved in establishing and running ELIXIR services are by their nature technical. The

The ESFRI Implementation Group (IG), a body established by ESFRI to identify and analyse the best practice and bottlenecks in the efficient implementation of ESFRI Research Infrastructures, has published its 2012 report. In the report, the Implementation Group report considers

ELIXIR took several important steps forward at its Interim Board meeting in Copenhagen on 22-23 April 2013. Most notably, ELIXIR Member States agreed the final version of the ELIXIR Consortium Agreement (ECA), which is the permanent legal basis for ELIXIR

The Spring edition of ELIXIR's Informed is available here. To register to subscribe automatically, please sign up here.

Representatives of ELIXIR Nodes came together in Noordwijk, Netherlands, for a two-day workshop on 21-22 March. The event was organised by NBIC, which is leading the Dutch ELIXIR Node. Participants came together to discuss issues including: how Nodes would respond

BioMedBridges, which is coordinated by ELIXIR, held its first Annual General Meeting in Dusseldorf, Germany, on 11-12 March. Further information on the event, including links to the presentations, is available here.

Bioinformatics has been given a strong endorsement in a recent Expert Group assesment on proposed Integrating Activity (I3) topics. I3s are European Commission-funded projects that provide funding to open up to other users existing national research infrastructures. Based on a

Hinxton, 5 Feb 2013 - The Interim ELIXIR Board is delighted to announce the appointment of Dr Niklas Blomberg to the newly created post of ELIXIR Founding Director. ELIXIR, the pan-European infrastructure for biological information, officially entered its implementation phase

A vacancy is currently open for the post of ELIXIR Scientific Administrator, as maternity cover, for a seven month period.

A vacancy is currently open for the post of ELIXIR Scientific Administrator, as maternity cover, for a seven month period.

ELIXIR MoU now has signature of 15 countries and EMBL Hinxton, 30 January 2013 – Greece is the latest country to join ELIXIR, the pan-European undertaking to safeguard the results of life science research. The ELIXIR Memorandum of Understanding (MoU)

The winter 2012/13 edition of Informed is now available. Register here to receive directly.

The ELIXIR Scientific Advisory Board (SAB) held its first meeting in December 2012. At the meeting, Dr Robert Gentleman of the biotech company Genentech was elected to the Chair, with Professor Gunnar von Heijne of Stockholm University elected Vice Chair

ELIXIR MoU has signature of 14 countries and EMBL Portugal has joined ELIXIR, the major European undertaking to safeguard the results of life science research. Portugal is the 14th nation to sign the ELIXIR Memorandum of Understanding (MoU): a first